Chief of Innovation
University Health Network, University of Toronto
Toronto, Ontario, Canada
Who to Transplant: Indication for Transplant, COPD, IPF, CF, Scleroderma, Sarcoidosis
Friday, January 26, 2024
8:20 AM - 8:35 AM CT
Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Session 5: Challenging Situations
Friday, January 26, 2024
3:50 PM - 4:30 PM CT
Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Sunday, January 28, 2024
7:00 AM - 7:30 AM CT
Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
Moderated Panel Q&A: Dealing with Airway Complications, Use of ECMO
Sunday, January 28, 2024
7:30 AM - 8:00 AM CT
Disclosure(s): Abbott: Advisory Board (Ongoing); CareDx: Advisory Board (Ongoing); CSL Behring: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Lung Bioengineering: Consultant (Ongoing); SQI Diagnostics: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated, October 22, 2023); Traferox Technologies: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); United Therapeutics: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)